Aviance Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,000
| Closed | -$1.03M | – | 235 |
|
|
2018
Q1 | $1.03M | Hold |
3,000
| – | – | 0.31% | 90 |
|
|
2017
Q4 | $1.13M | Hold |
3,000
| – | – | 0.37% | 73 |
|
|
2017
Q3 | $1.34M | Hold |
3,000
| – | – | 0.45% | 60 |
|
|
2017
Q2 | $1.47M | Hold |
3,000
| – | – | 0.47% | 58 |
|
|
2017
Q1 | $1.16M | Hold |
3,000
| – | – | 0.42% | 69 |
|
|
2016
Q4 | $1.1M | Hold |
3,000
| – | – | 0.39% | 74 |
|
|
2016
Q3 | $1.21M | Hold |
3,000
| – | – | 0.43% | 67 |
|
|
2016
Q2 | $1.05M | Hold |
3,000
| – | – | 0.39% | 74 |
|
|
2016
Q1 | $1.08M | Hold |
3,000
| – | – | 0.38% | 71 |
|
|
2015
Q4 | $1.63M | Hold |
3,000
| – | – | 0.56% | 44 |
|
|
2015
Q3 | $1.4M | Hold |
3,000
| – | – | 0.57% | 50 |
|
|
2015
Q2 | $1.53M | Hold |
3,000
| – | – | 0.57% | 44 |
|
|
2015
Q1 | $1.35M | Hold |
3,000
| – | – | 0.5% | 49 |
|
|
2014
Q4 | $1.23M | Hold |
3,000
| – | – | 0.46% | 58 |
|
|
2014
Q3 | $1.08M | Hold |
3,000
| – | – | 0.41% | 62 |
|
|
2014
Q2 | $847K | Hold |
3,000
| – | – | 0.33% | 94 |
|
|
2014
Q1 | $901K | Hold |
3,000
| – | – | 0.38% | 74 |
|
|
2013
Q4 | $826K | Hold |
3,000
| – | – | 0.35% | 77 |
|
|
2013
Q3 | $939K | Hold |
3,000
| – | – | 0.44% | 61 |
|
|
2013
Q2 | $675K | Buy |
+3,000
| New | +$675K | 0.36% | 81 |
|